Screener / SEC EDGAR /CIK 0001014739 /10-K filed Feb 24, 2026, compared with Feb 26, 2025 /Numbers from the XBRL of the 10-Ks
Health care peers:
Nasdaq Health care · Home Health Care Services

Option Care Health, Inc. OPCH

Option Care Health, Inc. (“Option Care Health”, “we”, “us”, “our”, or the “Company”) is the largest independent provider of home and alternate site infusion services through its national network of 196 locations in 43 states. 10-K, Item 1

Employees
2,700
Headquarters
Bannockburn, IL
Next results
around Jan 11, 2027
Compare with peers Embed

Where each dollar of revenue went, FY2025

Revenue of $5.6B through the costs to a net profit of $207.6M · income statement of the 10-K

6% operating margin
Revenue to Gross profit: $1.1BRevenue to Cost of revenue: $4.6BGross profit to Operating profit: $337.9MGross profit to Operating expenses: $750.0MOperating profit to Net profit: $207.6MOperating profit to Tax & other: $130.3M Revenue: $5.6B REVENUE $5.6B +13% Y/Y Gross profit: $1.1B · 19% margin GROSS PROFIT $1.1B 19% margin · +7% Y/Y Cost of revenue: $4.6B · 81% of revenue COST OF REVENUE $4.6B 81% of revenue Operating profit: $337.9M · 6% margin OPERATING PROFIT $337.9M 6% margin · +5% Y/Y Operating expenses: $750.0M · 13% of revenue OPERATING EXPENSES $750.0M 13% of revenue Net profit: $207.6M · 4% margin NET PROFIT $207.6M 4% margin · −2% Y/Y Tax & other: $130.3M · 2% of revenue TAX & OTHER $130.3M 2% of revenue
Gross profit $1.1B 19% margin · +7% Y/Y
Operating profit $337.9M 6% margin · +5% Y/Y
Net profit $207.6M 4% margin · −2% Y/Y
The full income statement, year by year

OPCH among Health care peers

Six ratios from the latest 10-K. Each corner is the share of 154 peers the company is above, not a score.

Compare
Revenue growth: 13.0%, above 60% of 154 peers (their median 10.4%) REVENUE GROWTH 13.0% · above 60% Gross margin: 19.1%, above 6% of 107 peers (their median 63.8%) GROSS MARGIN 19.1% · above 6% Operating margin: 5.9%, above 43% of 138 peers (their median 10.2%) OPERATING MARGIN 5.9% · above 43% Net margin: 3.7%, above 44% of 153 peers (their median 6.8%) NET MARGIN 3.7% · above 44% FCF margin: 4.9%, above 33% of 144 peers (their median 10.1%) FCF MARGIN 4.9% · above 33% Return on capital: 10.0%, above 56% of 89 peers (their median 9.0%) RETURN ON CAPITAL 10.0% · above 56%
OPCH Peer median Below the median

What changed

9 new risk paragraphs. 10-K filed Feb 24, 2026 against Feb 26, 2025.

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

Accounting checks

11 checks on the latest 10-K. Checks, not verdicts.

How it works

0facts worth reading about all 11 checks found nothing to note

  • Receivables +15.6% ($409.7M to $473.6M) vs revenue +13.0% ($5.0B to $5.6B), +2.5 pts apart
  • Cash from operations $258.4M vs net income $207.6M (FY ending Dec 31, 2025)
  • Inventory +21.4% ($388.1M to $471.1M) vs revenue +13.0% ($5.0B to $5.6B), +8.4 pts apart
8 more checks with nothing to note
  • Same auditor in both 10-Ks: KPMG LLP
  • No statement of substantial doubt about going concern
  • No 8-K item 4.02 in the last 2 years
  • No NT 10-K or NT 10-Q in the last 2 years
  • The same matters as last year: Sufficiency of audit evidence over the evaluation of transaction price adjustments
  • No sentence in the 10-K concludes that controls were not effective because of a material weakness
  • No 8-K item 2.06 in the last 2 years
  • No 8-K item 1.03 in the last 2 years

In their words

9 paragraphs in Risk Factors that were not in the 10-K filed Feb 26, 2025. Quoted as filed.

All 9 new paragraphs
  1. Item 1A · new paragraph · not in the 10-K filed Feb 26, 2025 10-K, ITEM 1A
    Increasing competition from established and vertically integrated healthcare providers, coupled with industry consolidation and cost pressures, may limit our ability to grow revenue, maintain pricing, secure favorable contracts, and access critical pharmaceutical products.
  2. Item 1A · new paragraph · not in the 10-K filed Feb 26, 2025 10-K, ITEM 1A
    Contracts and fee schedules for prescription drug reimbursement, including our contracts with commercial payers, PBMs, and Medicaid programs, generally use certain published benchmarks to establish pricing. These benchmarks include Average Wholesale Price (“AWP”), Wholesale Acquisition price (“WAC”), Average Selling Price (“ASP”), among…
  3. Item 1A · new paragraph · not in the 10-K filed Feb 26, 2025 10-K, ITEM 1A
    Our business could be adversely affected if we fail to effectively adopt and integrate evolving technologies such as artificial intelligence (“AI”), attract and retain necessary technical talent, or adapt to competitive, technological, or structural changes in the healthcare products and services industry, any of which could impair our…
  4. Item 1A · new paragraph · not in the 10-K filed Feb 26, 2025 10-K, ITEM 1A
    Ongoing reimbursement rate reductions, pricing pressures from Third-Party Payers and managed care payers, and increasing payer consolidation could significantly impact revenue, reduce profitability, and concentrate financial dependence on a few large payers.

New risk paragraphs, against peers

Latest 10-K of each, Health care companies closest in revenue

Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.

Financial performance

Last 4 fiscal years · 10-K XBRL

All years
MetricFY2022FY2023FY2024FY2025
Revenue$3.9B$4.3B$5.0B$5.6B
Net income$150.6M$267.1M$211.8M$207.6M
Operating cash flow$267.5M$371.3M$323.4M$258.4M
Free cash flow$232.2M$329.4M$287.8M$217.1M

Revenue, FY2016 to FY2025

Ten fiscal years, each from its own 10-K · XBRL · USD

$5.6B ▲ 13.0% in FY2025

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Every number, year by year

Recent filings

3 filings in the last 30 days · SEC EDGAR

All filings

About the company

Option Care Health, Inc., Bannockburn, IL · from the 10-K filed Feb 24, 2026

Option Care Health, Inc. (“Option Care Health”, “we”, “us”, “our”, or the “Company”) is the largest independent provider of home and alternate site infusion services through its national network of 196 locations in 43 states. Option Care Health draws on over 40 years of clinical care experience to offer patient-centered, cost-effective infusion therapy. Option Care Health’s infusion services include the clinical management of infusion therapy, nursing support and care coordination.

Headquarters
Bannockburn, IL
Country
United States
Reports in
USD
Listed on
Nasdaq
Fiscal year ends
December 31
Last results
Nov 4, 2026
Incorporated in
DE

Employees, at the top of the page: "The Company also provides nursing services to support the above therapies, comprised of its nursing team of approximately 2,700 employees, and through its network of sub-contracted nursing agencies" (10-K). Address and exchange: SEC's company file.

Email alerts

Sources

The 10-K filed Feb 24, 2026 (open at SEC), compared with the 10-K filed Feb 26, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.

Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/OPCH/export.csv") into a cell.

Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.